NuGene International, Inc. filed its 10-12G on Jul 11, 2022 for the period ending Dec 31, 2021. In this report its auditor, Olayinka Oyebola & Co, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0138 USD | +18.97% | +28.97% | +15.97% |
05-06 | Livento Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-01 | Livento Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+15.97% | 11.47M | |
+12.56% | 8.08B | |
+4.05% | 6.79B | |
+3.92% | 5.46B | |
+4.40% | 4.55B | |
+11.83% | 4.35B | |
+10.55% | 3.64B | |
+23.12% | 3.16B | |
-4.25% | 3.03B | |
+27.94% | 1.95B |
- Stock Market
- Equities
- NUGN Stock
- News Livento Group, Inc.
- NuGene International, Inc. Auditor Raises 'Going Concern' Doubt